Orthopedic caseload in surgical sealants, glues, hemostats

Opportunities for sealants, hemostasis, and closure products abound in the orthopedics field as investigators develop improved surgical procedures for patients with chronic disorders such as osteoarthritis, osteoporosis, and chronic back pain, and more rapid methods for repairing acute needs arising from sports injuries and trauma.

Many surgical interventions in this field involve total joint replacement using a metal or biomaterial implant, and most existing treatments aim to reduce the need for total joint reconstruction because of the trauma associated with such procedures. Sealants, hemostats and closure products offer the potential to augment surgical procedures designed to regenerate normal working of the affected part, and to help treat the underlying disorders.

Below is illustrated the U.S., European and Rest of World potential caseload for the application of surgical sealants, glues, hemostats and related products.  As is shown, fracture reduction and repair represents the biggest opportunity, followed by discetomy, whether in the U.S., Europe or Rest of World.  The RoW figures illustrated the most significant potential, while the realizable market has been primarily demonstrated  in the U.S. and Europe.

Source: MedMarket Diligence, LLC; Report #S180, “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015.”